SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000891554-02-000078
Filing Date
2002-01-09
Accepted
2002-01-09 00:00:00
Documents
4
Group Members
AVENTIS HOLDINGS INC.AVENTIS PHARMACEUTICALS INC.

Document Format Files

Seq Description Document Type Size
1 AMENDED GENERAL STATEMENT OF BENEFICIAL OWNERSHIP d27640_sc13da.txt SC 13D/A 17512
3 INFO. CON. DIRECTORS/EXECUTIVES OF API, AHI, RPR d27640_ex99-1.txt EX-99.1 8324
4 INFO. CON. SUPERVISORY BOARD/MGMT OF AVENTIS d27640_ex99-2.txt EX-99.2 4395
5 JOINT FILING AGREEMENT BY/AMONG API, AHI, RPR d27640_ex99-3.txt EX-99.3 1032
  Complete submission text file 0000891554-02-000078.txt   33932
Mailing Address
Business Address 500 ARCOLA RD P O BOX 1200 M/S 5B14 COLLEGEVILLE PA 19426-0107 6104548000
RHONE POULENC RORER INC (Filed by) CIK: 0000217028 (see all company filings)

IRS No.: 231699163 | State of Incorp.: PA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701
Business Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701 5127089310
INTROGEN THERAPEUTICS INC (Subject) CIK: 0001018710 (see all company filings)

IRS No.: 742704230 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-61001 | Film No.: 2505094
SIC: 2834 Pharmaceutical Preparations